MIRM
$80.14-2.73%
Mirum Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.008%Russell 3000 0.007%
MIRM financial statements
The full income statement, balance sheet, and cash-flow statement for Mirum Pharmaceuticals Inc. (MIRM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 47.7M2024-09 48.0M2024-12 49.0M2025-03 49.5M2025-06 50.2M2025-09 51.4M2025-12 60.3M2026-03 61.0M2026-06 64.9M+36.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 521M+54.7% | 337M+80.8% | 186M+141.8% | 77.1M+302.7% | 19.1M | |
| 543M+28.0% | 424M+43.6% | 296M+41.9% | 208M+8.2% | 193M+84.6% | ||
| Research & development | 186M+32.4% | 141M+37.1% | 103M-4.0% | 107M-18.7% | 131M+61.1% | |
| Selling, general & administrative | 257M+27.1% | 202M+38.6% | 146M+63.8% | 89.1M+50.4% | 59.2M+161.0% | |
| General & administrative | — | — | — | — | 59.2M+161.0% | |
| Amortization of intangibles | 23.9M+3.5% | 23.1M+120.0% | 10.5M+262.1% | 2.90M+866.7% | 300K | |
| Provision for credit losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating income | -22.1M+74.7% | -87.6M+19.7% | -109M+16.8% | -131M+24.3% | -173M-66.3% | |
| Interest expense | 14.4M+0.5% | 14.3M-5.3% | 15.1M-5.5% | 16.0M | — | |
| Interest & investment income | 12.7M-7.7% | 13.8M+0.4% | 13.7M+256.1% | 3.86M+953.8% | 366K-76.5% | |
| Other non-operating income | 2.37M+95.5% | 1.21M+143.0% | -2.82M-873.7% | 365K+162.7% | -582K-203.1% | |
| Pre-tax income | -21.4M+75.3% | -86.9M+46.5% | -162M-14.3% | -142M-69.2% | -84.0M+18.7% | |
| Income tax | 1.94M+88.0% | 1.03M+3.9% | 991K+115.5% | -6.41M-17413.5% | 37.0K+516.7% | |
| -23.4M+73.4% | -87.9M+46.2% | -163M-20.5% | -136M-61.5% | -84.0M+18.7% | ||
| Net income to common | — | -87.9M+46.2% | -163M-20.5% | -136M-61.5% | -84.0M | |
| -$0.47+74.6% | -$1.85+53.8% | -$4.00+0.5% | -$4.02-45.1% | -$2.77 | ||
| EPS (basic) | -$0.47+74.6% | -$1.85+53.8% | -$4.00+0.2% | -$4.01-44.8% | -$2.77 | |
| Weighted-avg shares (basic) | 50.2M+5.6% | 47.5M+16.2% | 40.9M+20.8% | 33.8M+11.6% | 30.3M | |
| Weighted-avg shares (diluted) | 50.2M+5.6% | 47.5M+16.2% | 40.9M+20.3% | 34.0M+12.1% | 30.3M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 550M+39.9% | 393M+1.4% | 388M+103.7% | 190M+14.2% | 167M-29.5% | ||
| Cash & equivalents | 297M+33.3% | 223M-22.3% | 286M+922.5% | 28.0M-10.6% | 31.3M-77.9% | |
| Short-term investments | 86.6M+49.9% | 57.8M | 0.00-100.0% | 124M-1.2% | 125M+39.5% | |
| Accounts receivable | 123M+57.5% | 78.3M+15.2% | 68.0M+183.3% | 24.0M+634.4% | 3.27M | |
| Inventory | 24.9M+11.1% | 22.4M+0.4% | 22.3M+300.9% | 5.57M+267.8% | 1.51M | |
| Prepaid expenses | 18.1M+53.9% | 11.8M+7.8% | 10.9M+22.2% | 8.95M+69.7% | 5.27M+16.4% | |
| 843M+25.7% | 671M+3.7% | 647M+83.2% | 353M+19.8% | 295M+22.3% | ||
| Property, plant & equipment | 1.86M+63.5% | 1.14M+61.3% | 706K-22.8% | 914K-6.8% | 981K-24.1% | |
| Operating lease right-of-use | 8.74M+0.8% | 8.68M+575.6% | 1.28M-10.3% | 1.43M-8.8% | 1.57M-19.5% | |
| Intangible assets | 261M+4.4% | 250M-1.2% | 253M+329.0% | 59.0M+214.6% | 18.7M | |
| Long-term investments | 8.11M-35.3% | 12.5M | 0.00 | 0.00-100.0% | 4.98M | |
| Other non-current assets | 12.0M+123.3% | 5.38M+29.2% | 4.17M+201.4% | 1.38M-22.6% | 1.79M+40.4% | |
| 206M+62.6% | 127M+45.4% | 87.1M+34.5% | 64.7M+52.0% | 42.6M+130.7% | ||
| Accounts payable | 9.61M-34.2% | 14.6M+97.1% | 7.42M-14.7% | 8.69M-5.2% | 9.17M+190.9% | |
| Accrued liabilities | 196M+75.3% | 112M+42.5% | 78.5M+45.4% | 54.0M+75.8% | 30.7M+129.1% | |
| Current lease liability | 2.14M+25.2% | 1.71M+54.8% | 1.10M+18.6% | 931K+30.9% | 711K+11.8% | |
| 528M+18.6% | 445M+11.9% | 398M+88.7% | 211M+20.9% | 174M+153.7% | ||
| Non-current lease liability | 7.52M-5.7% | 7.97M+1192.1% | 617K-50.9% | 1.26M-33.9% | 1.90M-27.6% | |
| Operating lease liability (total) | 9.65M-0.3% | 9.68M+462.5% | 1.72M-21.3% | 2.19M-16.3% | 2.61M-19.9% | |
| Other non-current liabilities | 5.01M+99.7% | 2.51M-34.8% | 3.85M-15.1% | 4.53M+26558.8% | 17.0K-41.4% | |
| 315M+39.5% | 226M-9.3% | 249M+75.1% | 142M+18.2% | 120M-30.1% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 5.00K+0.0% | 5.00K+0.0% | 5.00K+25.0% | 4.00K+33.3% | 3.00K+0.0% | |
| Additional paid-in capital | 982M+12.8% | 870M+8.3% | 803M+50.1% | 535M+41.8% | 377M+9.3% | |
| Retained earnings | -668M-3.6% | -644M-15.8% | -556M-41.6% | -393M-52.8% | -257M-48.5% | |
| Accumulated other comprehensive income | 351K+194.1% | -373K-122.7% | 1.64M+857.6% | -217K-520.0% | -35.0K-142.2% | |
| Total liabilities & equity | 843M+25.7% | 671M+3.7% | 647M+83.2% | 353M+19.8% | 295M+22.3% | |
| Common shares issued | 51.9M+7.4% | 48.3M+3.5% | 46.7M+26.4% | 37.0M+20.4% | 30.7M+2.2% | |
| Common shares outstanding | 51.9M+7.4% | 48.3M+3.5% | 46.7M+26.4% | 37.0M+20.8% | 30.6M+2.7% | |
| Shares outstanding (cover) | 60.3M+23.1% | 49.0M+4.3% | 47.0M+23.9% | 38.0M+19.6% | 31.7M+4.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 55.8M+440.7% | 10.3M+114.6% | -70.9M+40.9% | -120M+9.5% | -133M-49.0% | ||
| Depreciation & amortization | 24.2M+2.6% | 23.6M+118.2% | 10.8M+234.4% | 3.24M+444.2% | 595K+95.1% | |
| Intangible amortization | 23.9M+3.5% | 23.1M+120.0% | 10.5M+262.1% | 2.90M+866.7% | 300K | |
| Share-based compensation | 71.4M+47.4% | 48.4M+38.3% | 35.0M+29.7% | 27.0M+17.0% | 23.1M+83.9% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00+100.0% | -6.58M | 0.00 | |
| Change in receivables | 48.1M+320.6% | 11.4M-74.0% | 44.0M+112.2% | 20.7M | 0.00 | |
| Change in inventory | 8.45M+166.8% | 3.17M+225.1% | 974K-71.8% | 3.45M+596.6% | 495K | |
| -24.0M+73.4% | -90.1M+15.9% | -107M-1492.2% | 7.70M-84.1% | 48.5M+28.2% | ||
| Capital expenditure | 954K-3.9% | 993K+811.0% | 109K-60.8% | 278K+1058.3% | 24.0K-89.3% | |
| Free cash flow | 54.9M+488.0% | 9.33M+113.1% | -71.1M+41.0% | -120M+9.3% | -133M-48.7% | |
| Acquisitions | 0.00 | 0.00-100.0% | 213M | 0.00 | 0.00 | |
| Purchases of investments | 97.4M+9.4% | 89.0M+225.8% | 27.3M-79.3% | 132M-33.2% | 198M+165.6% | |
| Sales/maturities of investments | 74.4M+274.1% | 19.9M-87.0% | 153M+9.1% | 140M-9.8% | 156M+81.1% | |
| 40.1M+126.8% | 17.7M-94.7% | 337M+208.6% | 109M+48.5% | 73.5M-59.5% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 14.5M-32.0% | 21.3M | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 75.2M+218.7% | -63.4M-140.0% | 158M+4844.5% | -3.34M+68.9% | -10.7M-108.3% | |
| Interest paid | 12.7M+0.0% | 12.7M+85.6% | 6.82M | 0.00 | 0.00 | |
| Income taxes paid | 2.16M+114.8% | 1.00M+703.2% | 125K | 0.00 | 0.00-100.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 4.77B+135.2% | 2.03B+47.3% | 1.38B+91.4% | 719M+42.1% | 506M-4.7% | |
| P/S | 9.1×+52.0% | 6.0×-36.7% | 9.5×-30.8% | 13.7×-48.0% | 26.4× | |
| P/B | 15.1×+68.6% | 9.0×+75.6% | 5.1×+20.4% | 4.2×+0.9% | 4.2×+36.4% | |
| P/FCF | 86.9×-60.0% | 217.2× | — | — | — | |
| FCF yield | 1.2%+150.0% | 0.46% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: MIRM’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MIRM filings on SEC EDGAR → Not investment advice.